Tema Etfs LLC Akero Therapeutics, Inc. Transaction History
Tema Etfs LLC
- $241 Billion
- Q4 2024
A detailed history of Tema Etfs LLC transactions in Akero Therapeutics, Inc. stock. As of the latest transaction made, Tema Etfs LLC holds 32,150 shares of AKRO stock, worth $1.59 Million. This represents 0.37% of its overall portfolio holdings.
Number of Shares
32,150Holding current value
$1.59 Million% of portfolio
0.37%Shares
1 transactions
Others Institutions Holding AKRO
# of Institutions
210Shares Held
74.3MCall Options Held
321KPut Options Held
558K-
Wellington Management Group LLP Boston, MA7.38MShares$365 Million0.04% of portfolio
-
Rtw Investments, LP New York, NY6.86MShares$339 Million3.11% of portfolio
-
Janus Henderson Group PLC London, X06.03MShares$298 Million0.09% of portfolio
-
Black Rock Inc. New York, NY5.59MShares$276 Million0.0% of portfolio
-
General Atlantic LLC New York, NY5.23MShares$259 Million5.21% of portfolio
About Akero Therapeutics, Inc.
- Ticker AKRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,417,600
- Market Cap $2.29B
- Description
- Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...